Dual Action Therapy

Moxiscence LP

Antibiotic & Steroid Union

Moxiscence LP is a sophisticated combination of Loteprednol Etabonate and Moxifloxacin Hydrochloride. It is designed to provide comprehensive treatment for bacterial infections associated with significant steroid-responsive inflammation.

Synergy of Action

Loteprednol inhibits the inflammatory response and edema by converting into inactive metabolites quickly, while Moxifloxacin targets bacterial DNA replication enzymes (DNA gyrase/Topoisomerase IV) to eliminate infection.

Indications

Indicated for the treatment of bacterial conjunctivitis and secondary ocular inflammatory conditions.